Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Comparison of a Whole-Blood Interferon Gamma Assay With Tuberculin Skin Testing for Detecting Latent Mycobacterium Tuberculosis Infection. Journal of the American Medical Association. 286(14):1740-1747,October 10, 2001.

This report provides findings from a study designed to compare a whole-blood interferon gamma assay, the QuantiFERON-TB test, with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection and to identify factors associated with discordance between the tests.

Author:

Mazurek, G.H.; LoBue, P.A.; Daley, C.L.; Bernardo, J.; Lardizabal, A.A.; Bishai, W.R.; Iademarco, M.F.; Rothel, J.S.

Topic:

Diagnosis, TB Skin Test, Treatment - Latent TB infection (Inactive TB)

Language:

English

Country of Origin:

United States

View Webpage

Related Materials

Interferon-Gamma Release Assays (IGRAs) - Blood Tests for TB Infection

This information sheet discusses interferon-gamma release assays (IGRAs), which are whole-blood tests used in diagnosing both latent TB infection and TB disease. It notes that two IGRAs have been approved by the US Food and Drug Administration (FDA) and are commercially available in the United States. The information sheet explains how the IGRAs work; the advantages, disadvantages, and limitations of IGRAs; steps in administering these tests; interpretation; recommendations on when to use them; and whether IGRAs can be given to persons receiving vaccinations.

Information Sheet

Interferon-Gamma Release Assays (IGRAs) - Blood Tests for TB Infection

This fact sheet provides guidance to health-care providers for use of IGRAs in the diagnosis of M. tuberculosis infection in adults and children.

Fact Sheet

Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection – United States, 2010

This serial presents updated guidelines to US public health officials, healthcare providers, and laboratory workers for use of FDA-approved interferon gamma release assays (IGRAs) to diagnose both active and latent TB infection in adults and children. These guidelines include use of the QuantiFERON-TB Gold In-Tube Test (QFT-GIT) and the T-SPOT.TB Test (T-Spot), two new IGRAs that were not included in the previous guidelines published in 2005. The antigens, methods, and interpretation criteria for these assays differ from those for IGRAs approved previously. Although there has been progress in documenting the utility of IGRAs, further studies and research are needed. Specific areas needing additional research are listed.

Guideline

Global resources for the prevention,
management, and elimination of TB.